Betsy O. Spaulding

IGF2BP3 (IMP3) expression is a marker of unfavorable prognosis in ovarian carcinoma of clear cell subtype

Martin Köbel, Haodong Xu, Patricia Bourne et al. · Modern Pathology · 2009 · 137 citations · Full text

Medicine, Oncology, Pathology +15

Comparison of different antibodies for detection of progesterone receptor in breast cancer

Michael F. Press, Betsy O. Spaulding, Susan Groshen et al. · Steroids · 2002 · 86 citations

Medicine, Endocrinology, Oncology +16

IMP-3 is a novel progression marker in malignant melanoma

Jennifer G. Pryor, Patricia Bourne, Qi Yang et al. · Modern Pathology · 2008 · 81 citations · Full text

Medicine, Cancer Biology, Oncology +14

S100P, von Hippel-Lindau gene product, and IMP3 serve as a useful immunohistochemical panel in the diagnosis of adenocarcinoma on endoscopic bile duct biopsy

Mary Levy, Fan Lin, Haodong Xu et al. · Human Pathology · 2010 · 75 citations

Medicine, Oncology, Pathology +16

High-grade neuroendocrine carcinomas of the lung express K homology domain containing protein overexpressed in cancer but carcinoid tumors do not

Haodong Xu, Patricia Bourne, Betsy O. Spaulding et al. · Human Pathology · 2007 · 72 citations

Medicine, Molecular Biology, Oncology +15